Chapter 05 · Validation & Evidence

Validation & Evidence as a reviewable surface.

Validation evidence for Medicines connects technical performance to the real workflow, population, user, and decision context.

Focus: medicine lifecycle · PV · benefit-riskRisk: signal distortion and weak traceabilityBridge: case · evidence · action
Medicines traceCaseSignalBenefitRiskActionReviewAIsystemsource to workflow to evidence to review
/ 05

Validation & Evidence chapter.

Medicines

Validation evidence for Medicines connects technical performance to the real workflow, population, user, and decision context.

/ A

What this page maps.

operating content
Performance

Performance

Accuracy, sensitivity, specificity, precision, calibration, robustness, subgroup performance, and error analysis where relevant.

Workflow fit

Workflow fit

Usability, human review, override behavior, documentation burden, failure mode, and operational reliability.

Decision record

Decision record

Acceptance criteria, approval rationale, limitations, monitoring obligations, and next review date.

/ B

Governance questions.

review logic
Question

What decision or record does this validation & evidence surface influence, and who owns that decision?

Question

Which evidence is needed before routine use in Medicines, and where is it retained?

Question

What signal triggers review, restriction, escalation, or retirement?

/ evidence

Evidence-ready minimum record.

iFeed use
Minimum record
OwnerNamed operational, clinical, technical, and governance owners.
UseClear intended use, user group, workflow point, and excluded use.
RiskRisk tier, rationale, residual risks, controls, and escalation route.
EvidenceSource claims, validation basis, limitations, approval decision, and review date.
/ sources

Source anchors and claim boundary.

official first

These anchors support the source layer for this page. iFeed interpretation remains separate from source facts and does not replace legal, regulatory, clinical, or product-specific advice.